Incyte Corporation v. Incysus Therapeutics, Inc

Court

District Court, D. Delaware (D. Del.)
Official Court Website →

Assigned judge

Colm F. Connolly · 1,962 cases in index

Docket number

1:19-cv-01451

Cause

15:1051 Trademark Infringement
15 U.S.C. § 1051 — Lanham (Trademark) Act

Nature of suit

840 Trademark
Infringement or dilution of a trademark under the Lanham Act.

Jurisdiction

Federal Question

Jury demand

Plaintiff

Date filed

08/01/2019

Date terminated

12/02/2019

477 Trademark cases in this court are indexed here.

Parties

• plaintiff · Incyte Corporation Research & Development Services · 15 cases
• defendant · Incysus Therapeutics, Inc

Part of a Larger Litigation Pattern

This is one of 2 Trademark cases in our index naming Incysus Therapeutics, Inc — a possible mass-tort or coordinated-litigation cluster.

About Trademark Lawsuits

Trademark lawsuits allege infringement or dilution of a brand name, logo, or other mark under the Lanham Act — typically claims that one party's use is likely to confuse consumers about the source of goods or services.

Frequently Asked Questions

What is Incyte Corporation v. Incysus Therapeutics, Inc?

Incyte Corporation v. Incysus Therapeutics, Inc is a federal trademark lawsuit filed on 08/01/2019 in the District Court, D. Delaware. The case was terminated on 12/02/2019. Trademark lawsuits allege infringement or dilution of a brand name, logo, or other mark under the Lanham Act — typically claims that one party's use is likely to confuse consumers about the source of goods or services.

What type of case is this?

It is classified as “Trademark” under the federal nature-of-suit system. Trademark lawsuits allege infringement or dilution of a brand name, logo, or other mark under the Lanham Act — typically claims that one party's use is likely to confuse consumers about the source of goods or services.

What court is the case in?

The case is in the District Court, D. Delaware, docket number 1:19-cv-01451.

When was the case filed?

Incyte Corporation v. Incysus Therapeutics, Inc was filed on 08/01/2019. It was terminated on 12/02/2019.

What law is the case brought under?

The docket lists the cause as 15 U.S.C. § 1051 — Lanham (Trademark) Act.